Back | Next |
home / stock / nvus / nvus message board
Subject | By | Source | When |
---|---|---|---|
Bad news. | willlbone | investorshub | 04/22/2019 7:05:55 PM |
Been watching it, should have bought it under | Mark | investorshub | 02/01/2019 1:28:39 AM |
NVUS on the move | TheFinalCD | investorshub | 01/31/2019 8:53:58 PM |
* * $NVUS Video Chart 09-07-18 * * | ClayTrader | investorshub | 09/07/2018 9:14:20 PM |
https://finance.yahoo.com/news/novus-therapeutics-postpone-offering-common-13250 | TheFinalCD | investorshub | 09/07/2018 1:56:08 PM |
$NVUS News: Withdrawal of Registration Statement (rw) 09/07/2018 09:02 | TheFinalCD | investorshub | 09/07/2018 1:20:54 PM |
Novus Acquisition and Development, Corp. (OTC PINK: $NDEV), | Mariijuana Invest | investorshub | 08/20/2018 1:07:33 PM |
Novus Acquisition and Development, Corp. (OTC PINK: $NDEV), | Mariijuana Invest | investorshub | 08/20/2018 1:07:32 PM |
still watching.. will wait for a capitulating dip, | FairviewInvestor | investorshub | 06/25/2018 5:29:27 PM |
Sure. wish I'd sold $2 higher, but price | FairviewInvestor | investorshub | 06/18/2018 5:41:46 PM |
Sold all in the $6.28 to $6.40 range.. | FairviewInvestor | investorshub | 05/15/2018 7:22:48 PM |
Finally green again... | FairviewInvestor | investorshub | 05/14/2018 6:43:32 PM |
$NVUS great. A golden cross is the | ash111 | investorshub | 04/16/2018 7:25:42 AM |
$NVUS, 4.96 golden cross occurred this past Friday, chart: | Mark | investorshub | 04/15/2018 11:32:40 PM |
$NVUS Novus Therapeutics Inc ($NVUS) Holdings Lifted by | ash111 | investorshub | 04/03/2018 2:57:03 PM |
Didn't sell any today. for the length | FairviewInvestor | investorshub | 03/16/2018 8:31:37 PM |
6.22 hod. "43.53% of the stock is currently | ash111 | investorshub | 03/16/2018 7:49:12 PM |
rule usually to take 1/2 off on going | FairviewInvestor | investorshub | 03/15/2018 5:42:55 PM |
News comings soon. . . | toomorrow | investorshub | 03/15/2018 4:43:07 PM |
@Fairview... all I wanted to do was dump | Giddycarol30 | investorshub | 03/15/2018 3:39:10 AM |
News, Short Squeeze, Breakout and More Instantly...
Novus Therapeutics Inc. Company Name:
NVUS Stock Symbol:
NASDAQ Market:
Novus Therapeutics Inc. Website:
Eledon to commence trading on the Nasdaq exchange under the ticker “ELDN” effective tomorrow, January 5, 2021 Eledon is well financed to complete up to four Phase 2 clinical trials of lead candidate AT-1501, a potential best in class anti-CD40L monoclonal antibody ...
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those l...
Former Chief Development and Chief Operating Officer of MyoKardia, Inc. brings extensive clinical development expertise as Novus prepares to conduct up to four Phase 2 clinical trials Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharma...